Furthermore, CYThigh prostate cancer patients are more sensitive to ICIs due to the fact that high GZMA and PRF1 expression levels increase the number of CD8+ T cells and the expression of immune checkpoints, including PD-L1, compared to patients with low CYT levels [112]. The gene discussed is PRF1; the disease is prostate carcinoma.